|Page (1) of 1 - 10/19/12||email article||print page|
Olea Medical Launches Olea SphereTM Medical Imaging Enterprise Software Package in the US(October 19, 2012)
La Ciotat (PRWEB) October 19, 2012
Olea Medical, a provider of advanced MR and CT perfusion imaging post-processing announces launching the Olea SphereTM medical imaging enterprise software package in the US. Olea Medical received the FDA 510(k) clearance to market the Olea package in the US earlier this year.
Olea SphereTM is an image processing software package intended for picture archive, post-processing and communication. It helps standardize both viewing and analysis capabilities of functional and dynamic imaging datasets acquired with MRI and CT across vendors. It features innovative image viewing and analysis, processing of perfusion weighted image post-processing, permeability computation, as well as diffusion weighted image/tensor image post-processing, fiber tracking post-processing, and longitudinal analysis of multiple time points.
It is compliant with the DICOM standard and Windows, Macintosh or Linux operating systems. It runs on any standard off-the-shelf workstation or it can be used through a thin deployment with a server. The DWI Module is used to visualize local water diffusion properties from the analysis of diffusion-weighted MRI data. The Fiber Tracking feature utilizes the directional dependency of the diffusion to display different structures within anatomic areas of interest. The perfusion analysis module is used for visualization and analysis of dynamic imaging data, showing properties of changes in contrast over time. Both DSC and DCE MRI perfusion sequences are supported to cover full body analysis.
"In neuro-oncology, the role of imaging is to assess the nature and extent of disease, however the information provided with structural imaging is limited, particularly when acquired during the course of patient therapy. Advanced information from perfusion, permeability and diffusion tensor tractography imaging assists in determining lesion grade and extent, differentiation of treatment related changes from viable tumor and serves as a guide to the appropriate lesion resection trajectory. To be valid in practice, an advanced rendering engine must be reliable, accurate and be science-based. To be integral to the clinical process it must be fast, easy to use and accessible enterprise-wide," said Lawrence Tanenbaum, MD, Associate Professor of Radiology at The Mount Sinai Hospital, New York. "Olea SphereTM meets these lofty requirements and more than satisfies our everyday advanced neuroimaging needs," he added.
"The launching of Olea Sphere is a major milestone in the development of the company. During the past years, Olea Medical has gained recognition from neuroradiologists for our expertise in neuro-imaging. With Olea SphereTM we are now covering the full body, regardless of the modality employed for image acquisition. This is a tremendously important development, especially for oncology but also for hepatic disorders or kidney dysfunction," says Fayçal Djeridane, president and CEO of Olea Medical. "Also, Olea SphereTM has been specifically designed to incorporate future innovative modules, to cover various modalities, such as spectroscopy or ASL. Olea SphereTM shows Olea Medicals commitment to providing a widely accessible, complete package of simple, safe, fast and accurate tools for full-body image post-processing in order to help doctors improve the diagnosis and follow-up process for patients benefit," he added.
About Olea Medical:
Olea Medical designs and markets innovative medical imaging applications that significantly improve diagnostic processes and treatment evaluation. Olea Medical aims to become the leading provider of safe and accurate medical imaging software. More information at http://www.olea-medical.com.
Read the full story at http://www.prweb.com/releases/2012/10/prweb10030263.htm.
Related Keywords:medical procedure/test, medical research, medical staff, medical specialisation, medical service, medical conditions